Vir Biotechnology, Inc.
VIR
$9.40
$0.111.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 62.11M | 63.30M | 12.65M | 14.79M | 16.66M |
| Total Other Revenue | 3.39M | 5.25M | 4.21M | 4.21M | 4.21M |
| Total Revenue | 65.50M | 68.56M | 16.86M | 19.00M | 20.86M |
| Cost of Revenue | 447.24M | 455.04M | 469.53M | 513.30M | 520.95M |
| Gross Profit | -381.74M | -386.49M | -452.67M | -494.30M | -500.09M |
| SG&A Expenses | 91.47M | 92.07M | 95.16M | 98.67M | 106.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 538.71M | 547.12M | 564.68M | 611.97M | 627.60M |
| Operating Income | -473.21M | -478.56M | -547.82M | -592.97M | -606.74M |
| Income Before Tax | -442.35M | -437.77M | -499.39M | -549.95M | -579.05M |
| Income Tax Expenses | 371.00K | 217.00K | 268.00K | 277.00K | -1.41M |
| Earnings from Continuing Operations | -442.72 | -437.99 | -499.65 | -550.23 | -577.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -442.72M | -437.99M | -499.65M | -550.23M | -577.65M |
| EBIT | -473.21M | -478.56M | -547.82M | -592.97M | -606.74M |
| EBITDA | -461.59M | -466.88M | -536.16M | -581.41M | -593.83M |
| EPS Basic | -3.14 | -3.16 | -3.62 | -4.01 | -4.22 |
| Normalized Basic EPS | -1.94 | -1.98 | -2.27 | -2.46 | -2.49 |
| EPS Diluted | -3.14 | -3.16 | -3.62 | -4.01 | -4.22 |
| Normalized Diluted EPS | -1.94 | -1.98 | -2.27 | -2.46 | -2.49 |
| Average Basic Shares Outstanding | 563.97M | 554.08M | 551.66M | 549.38M | 547.16M |
| Average Diluted Shares Outstanding | 563.97M | 554.08M | 551.66M | 549.38M | 547.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |